The Flowr Corporation Stock Toronto S.E.
Equities
FLWR.H
CA34354X1087
Pharmaceuticals
Sales 2020 | 7.51 10.23 | Sales 2021 | 12.35 16.82 | Capitalization | 22.37M 30.47M |
---|---|---|---|---|---|
Net income 2020 | -126M -172M | Net income 2021 | -85M -116M | EV / Sales 2020 | 16,546,858 x |
Net Debt 2020 | 29.2M 39.77M | Net Debt 2021 | 17.1M 23.29M | EV / Sales 2021 | 3,196,178 x |
P/E ratio 2020 |
-0.35
x | P/E ratio 2021 |
-0.24
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 65.85% |
1st Jan change | Capi. | |
---|---|---|
+45.15% | 6.38B | |
-14.00% | 4.59B | |
+9.54% | 3.39B | |
-8.99% | 3.2B | |
+50.03% | 2B | |
-6.97% | 1.7B | |
-0.31% | 1.65B | |
+50.00% | 1.55B | |
-10.61% | 1.58B |